srr_id,download_timestamp,summary_runs,summary_total_spots,summary_total_size,run_accession,run_total_spots,run_total_bases,run_size,run_published,run_attr_assembly,experiment_accession,experiment_title,library_strategy,library_source,library_selection,library_layout,library_name,design_description,platform_type,instrument_model,exp_attr_alignment_software,sample_accession,sample_title,organism,taxon_id,sample_description,sample_gap_accession,sample_submitter_handle,sample_biospecimen_repository,sample_study_name,sample_study_design,sample_biospecimen_repository_sample_id,sample_submitted_sample_id,sample_submitted_subject_id,sample_gap_sample_id,sample_gap_subject_id,sample_sex,sample_study_disease,sample_body_site,sample_analyte_type,sample_is_tumor,sample_subject_is_affected,sample_gap_consent_code,sample_gap_consent_short_name,study_accession,study_title,study_abstract,study_description,study_type,study_attr_parent_bioproject,submission_accession,submission_date,center_name,lab_name,organization_type,organization_name,sample_isolate,sample_age,sample_biomaterial_provider,sample_collection_date,sample_geo_loc_name,sample_tissue,sample_biosamplemodel,run_attr_ENA-FIRST-PUBLIC,run_attr_ENA-LAST-UPDATE,sample_ena_first_public,sample_ena_last_update,sample_external_id,sample_insdc_center_alias,sample_insdc_center_name,sample_insdc_first_public,sample_insdc_last_update,sample_insdc_status,sample_submitter_id,sample_common_name,sample_environment_(biome),sample_environment_(feature),sample_environment_(material),sample_geographic_location_(country_and/or_sea),sample_geographic_location_(latitude),sample_geographic_location_(longitude),sample_human_associated_environmental_package,sample_investigation_type,sample_project_name,sample_sample_name,sample_sequencing_method,sample_strain,sample_treatment,sample_replicate,sample_breed,sample_cultivar,sample_ecotype,sample_dev_stage,sample_disease,exp_attr_Experimental Factor: clinical information,sample_broker_name,sample_clinical_information,sample_developmental_stage,sample_individual,sample_organism_part,study_attr_ENA-FIRST-PUBLIC,study_attr_ENA-LAST-UPDATE,sample_sample_type,sample_xanthomas,sample_xanthelasmas,sample_arcus_cornealis,sample_tendon_thickness,sample_presence_of_disease_complications,sample_total_cholesterol_(mg/dl),sample_hdl_c_(mg/dl),sample_ldl_c_(mg/dl),sample_triglycerides_(mg/dl),sample_molecular_data_type,sample_source_name,sample_cell_type,sample_genotype,sample_sub_species,exp_attr_GEO Accession,sample_subject_status,sample_gender,sample_antibody,run_attr_loader,sample_cell_line,sample_rip_antibody,sample_maturity,sample_growth_protocol,sample_time,sample_clinical_group,sample_disease_status,sample_defect,sample_sample_id,sample_disease_state,run_attr_intentional_duplicate,sample_bmi,sample_degree_of_aortic_valve_disease,sample_left_ventricle_ejection_fraction,sample_other_medical_history,sample_isolation_source,sample_host,sample_env_broad_scale,sample_env_local_scale,sample_env_medium,sample_host_disease,sample_lat_lon,sample_disease_stage,sample_ethnicity,sample_phenotype,sample_method,sample_factor,sample_condition,exp_attr_Experimental Factor: disease,sample_day_post_differentiation,sample_genotype/variation,sample_chip_antibody,sample_agent,sample_aortic_valve_anatomy,sample_health_state,sample_donor_id,sample_lab,sample_source,study_attr_GEO Accession,study_attr_Project Contact,study_attr_Project Contributor,sample_age_at_diagnosis_years,sample_clinical_notes,sample_scientific_name,sample_tissue_type,study_attr_stomatocytosis,study_attr_whole-genome sequencing,study_attr_red blood cell,sample_protocol,sample_cell/sample_type,sample_organism,run_attr_options,sample_mutation,run_attr_ENA-STATUS-ID,exp_attr_ENA-STATUS-ID,study_attr_ENA-STATUS-ID,sample_sample_comment,sample_gap_parent_phs,study_attr_parent_gap_accession,sample_layer,sample_sex_age,sample_race,sample_group,sample_cell_subtype,sample_day,sample_name_in_supplementary_file,exp_attr_Experimental Factor: immunophenotype,sample_clinical_history,sample_immunophenotype,sample_inferred_cell_type,sample_development_stage,sample_passages,sample_diagnosis,sample_time_point,run_attr_flowcell_barcode,run_attr_gssr_id,run_attr_instrument_name,run_attr_lane,run_attr_lsid,run_attr_molecular_indexing_scheme,run_attr_project,run_attr_read_group_id,run_attr_read_group_platform_unit,run_attr_root_sample_id,run_attr_run_barcode,run_attr_run_name,run_attr_sample_id,run_attr_work_request,exp_attr_gssr_id,exp_attr_lsid,exp_attr_material_type,exp_attr_primary_disease,exp_attr_project,exp_attr_root_sample_id,exp_attr_sample_id,exp_attr_target_set,exp_attr_work_request,sample_histological_type,sample_number_of_cells,sample_stimulus,sample_sample_date,sample_azi_switch_date,sample_ltx_date,sample_clad_ever,sample_il6_pg_ml,sample_il8_pg_ml,sample_fev1_percent_predicted,sample_acute_rejection,sample_lymphocytic_bronchiolitis,sample_crp_mg_l,sample_absolute_neutrophils,sample_absolute_macrophages,sample_absolute_lymphocytes,sample_absolute_eosinophils,sample_total_cell_count,sample_16s_copies_per_ml_bal,sample_richness_numspec,sample_shannon_even,sample_shannon_diversity,sample_subject_id,sample_treatment_protocol,sample_isol_growth_condt,exp_attr_Experimental Factor: genetic modification,sample_progenitor_cell_type,sample_genetic_modification,sample_collection_method,sample_host_age,sample_host_body_mass_index,sample_host_height,sample_host_sex,sample_host_tissue_sampled,sample_host_tot_mass,sample_status,sample_source_material_id,sample_horse,sample_visit,sample_sample_order,sample_dob,sample_age_of_collection_days,sample_month_norm,sample_sample_age,sample_equine_sex,sample_breed_type,sample_disease_category,sample_disease_category_healthy,sample_disease_category_acute_gi,sample_disease_category_musculoskeletal,sample_disease_category_ocular,sample_disease_category_integumentary,sample_disease_category_respiratory,sample_disease_category_chronic_gi,sample_disease_category_neurologic,sample_disease_category_dental,sample_disease_category_reproductive,sample_disease_category_systemic,sample_disease_category_cardiovascular,sample_disease_category_immune_mediated,sample_disease_category_urinary,sample_euthanasia_death,sample_sampleid,sample_feed_pasture,sample_feed_hay,sample_feed_grain,sample_feed_nursing,sample_city,sample_state,sample_zip,sample_birth_date,sample_birth_location,sample_breeding_history,sample_breeding_method,sample_collected_by,sample_population,completeness,completeness_pct
SRR31051507,2025-11-17T08:25:48.527261,"                                <Run acc=""SRR31051507"" total_spots=""100983"" total_bases=""50693466"" load_done=""true"" is_public=""true"" cluster_name=""public"" static_data_available=""true""/>                                ",,,SRR31051507,100983.0,50693466.0,31011461.0,2024-10-21 01:05:40,,SRX26436077,16S rRNA amplicon sequencing of equine fecal microbiome,AMPLICON,METAGENOMIC,PCR,PAIRED,AE1362,16S rRNA amplicon seqeuncing of V4 region (515F/806R),ILLUMINA,Illumina MiSeq,,SRS22952756,,gut metagenome,749906.0,,,,,,,,,,,,female,,,,,,,,SRP468386,Longitudinal and single timepoint analysis of the fecal microbiome of horses at eight teaching hospitals on three continents,"These 16S rRNA amplicon sequencing data were generated from DNA isolated from the feces of horses and other equids admitted to one of eight veterinary teaching hospitals within the United States, United Kingdom, or Australia. Fecal samples were collected from healthy horses and horses with adverse health conditions affecting any body system, immediately upon admission and, in some horses, longitudinally throughout their hospitalization. Metadata include patient demographics and information related to health status, diagnosis, treatment, and outcome associated with each horse.",,,,SRA1994305,,University of MIssouri,Department of Veterinary Pathobiology,institute,University of MIssouri,,,,2020-11-10,USA:University of Missouri,,Metagenome or environmental,,,,,,,,,,,,,,,,,,,,,,,,,flunixin,,Paint Horse,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Equine fecal microbiome,Equus caballus,,,,,38.94 N 92.32 W,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Dilated cardiomyopathy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Horse:8579220_Visit1_Sample:1,8579220.0,1.0,1.0,2010-11-01T00:00:00,2020-11-10T00:00:00,11.3333333333333,1.0,Mare,Other,Cardiovascular,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,yes,AE1362,0.0,0.0,0.0,0.0,Walnut Grove,MO,65770.0,,,,,,,45,20.930232558139537
SRR7739277,2025-11-17T08:04:48.261925,,,,SRR7739277,62388.0,28029142.0,16747140.0,2019-08-20 12:40:43,,SRX4595700,16S rRNA-seq post-LTx BAL,AMPLICON,GENOMIC,PCR,PAIRED,L048V3,DNA extracted from BAL and 16S rRNA amplicon libraries prepared using 4-step library preparation protocol using primers targeting 515F/806R region (v4) of the gene,ILLUMINA,Illumina MiSeq,,SRS3701813,,Homo sapiens,9606.0,,,,,,,,,,,,male,,,,,,,,SRP158593,Impact of azithromycin and allograft rejection on the post-lung transplant (LTx) microbiota,"Determine if azithromycin could have beneficial effects after LTx by modulation post-LTx bronchoalveolar lavage (BAL) microbiota, if changes in BAL microbiota in the first 2 years after LTx are linked to acute and chronic rejection development and how post-LTx BAL microbiota correlates with levels of inflammatory cytokines.",,,,SRA761888,,Queen's University Belfast,Pharmacy,institute,Queen's University Belfast,L048V3,22 years at transplant,"Dr Stijn Verleden, Leuven Lung Transplant Unit, Department of Chronic Diseases, Metabolism and Ageing, KU Leuven, Leuven, Belgium",,,Bronchoalveolar lavage (BAL),Human,,,,,,,,,,,,,,,,,,,,,,,,,AZITHROMYCIN,,,,,2 year,Congenital restrictive cardiomyopathy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2008-02-14,not applicable,2006-02-23T00:00:00,no,0.059,50.513,104.0,not collected,not collected,0.5,0.109068,0.119804,0.0017079999999999,0.0,0.122,7569.186960923121,48.0,0.3713527617566395,1.4375811867157402,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,29,13.488372093023257
SRR7739279,2025-11-17T08:41:24.858448,"                                <Run acc=""SRR7739279"" total_spots=""224587"" total_bases=""75563423"" load_done=""true"" is_public=""true"" cluster_name=""public"" static_data_available=""true""/>                                ",,,SRR7739279,224587.0,75563423.0,49022363.0,2019-08-20 12:40:43,,SRX4595698,16S rRNA-seq post-LTx BAL,AMPLICON,GENOMIC,PCR,PAIRED,L048V1,DNA extracted from BAL and 16S rRNA amplicon libraries prepared using 4-step library preparation protocol using primers targeting 515F/806R region (v4) of the gene,ILLUMINA,Illumina MiSeq,,SRS3701811,,Homo sapiens,9606.0,,,,,,,,,,,,male,,,,,,,,SRP158593,Impact of azithromycin and allograft rejection on the post-lung transplant (LTx) microbiota,"Determine if azithromycin could have beneficial effects after LTx by modulation post-LTx bronchoalveolar lavage (BAL) microbiota, if changes in BAL microbiota in the first 2 years after LTx are linked to acute and chronic rejection development and how post-LTx BAL microbiota correlates with levels of inflammatory cytokines.",,,,SRA761888,,Queen's University Belfast,Pharmacy,institute,Queen's University Belfast,L048V1,22 years at transplant,"Dr Stijn Verleden, Leuven Lung Transplant Unit, Department of Chronic Diseases, Metabolism and Ageing, KU Leuven, Leuven, Belgium",,,Bronchoalveolar lavage (BAL),Human,,,,,,,,,,,,,,,,,,,,,,,,,AZITHROMYCIN,,,,,discharge,Congenital restrictive cardiomyopathy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2006-03-24,not applicable,2006-02-23T00:00:00,no,0.245,7.43,53.0,0,0,1.6,0.00078,0.3861,0.00312,0.0,0.39,not collected,51.0,0.5642299341217202,2.218453717730137,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,29,13.488372093023257
ERR4851519,2025-11-17T07:59:14.861055,"                                <Run acc=""ERR4851519"" total_spots=""48421928"" total_bases=""4406395448"" load_done=""true"" is_public=""true"" cluster_name=""public"" static_data_available=""true""/><Run acc=""ERR4851520"" total_spots=""49157668"" total_bases=""4473347788"" load_done=""true"" is_public=""true"" cluster_name=""public"" static_data_available=""true""/>                                ",,,ERR4851519,48421928.0,4406395448.0,1421521932.0,2020-11-20 13:43:46,,ERX4720942,Illumina NovaSeq 6000 sequencing; Paired scRNAseq of the and non-hematopoietic and the immune microenvironment of aspirates from newly diagnosed Multiple Myeloma patients versus non-cancer controls,RNA-Seq,TRANSCRIPTOMIC SINGLE CELL,RANDOM,SINGLE,Sample 50_p,Paired scRNAseq of the and non-hematopoietic and the immune microenvironment of aspirates from newly diagnosed Multiple Myeloma patients versus non-cancer controls,ILLUMINA,Illumina NovaSeq 6000,,ERS5345986,Sample 50,Homo sapiens,9606.0,"Protocols: Viably frozen bone marrow aspirates were thawed in DMEM + 10% FCS according to the 10X Genomics protocol 'Fresh Frozen Human Peripheral Blood Mononuclear Cells for Single Cell RNA sequencing'. Only samples containing >200x10E6 MNCs were included. Fc receptors were blocked in 10% normal human AB serum (Sigma-Aldrich). To enrich for stromal fibroblasts, samples were incubated with biotinylated antibodies against CD45 (clone HI30, BioLegend), CD235a (clone HIR2, BioLegend) and CD38 (from human CD38 MicroBead Kit, Miltenyi Biotec) followed by depletion using magnetic anti-biotin beads (Miltenyi Biotec) and the iMag (BD Biosciences). After depletion, cells were stained for sorting in PBS containing 2% FCS at 4°C with the following antibodies: CD271-PE (ME20.4), CD235a-PECy7 (HI264), CD31-APCCy7 (WM59), CD44-BV711 (IM7), streptavidin-BV421 (all BioLegend), CD34-PECF610 (4H11, eBioscience), CD45-APC (2D1, eBioscience), CD38-FITC (MHCD3801, Life Technologies), CD71-Alexa Fluor 700 (MEM-75, ExBio) and CD105-BV510 (266, BD Biosciences). 7AAD (Beckman Coulter) or DAPI (Life Technologies) were used for dead cell exclusion. Cells were sorted in DMEM + 10% FCS using a FACSAria III (BD Biosciences). Prior to depletion, 10x106 cells were used to sort CD45+CD38- and CD38+ hematopoietic populations using the same antibody panel. Sorted CD45- cells were combined with sorted CD45+CD38- cells and processed as one sample. Single cells were encapsulated for cDNA synthesis and barcoded using the Chromium Single Cell 3' Reagent Kit v3 (10X Genomics) Libraries were constructed according to the manufacturer's recommendations (10X Genomics)",,,,,,,,,,,male,,,,,,,,ERP122056,Paired scRNAseq of the and non-hematopoietic and the immune microenvironment of aspirates from newly diagnosed Multiple Myeloma patients versus non-cancer controls,"By generating a paired single cell RNA-sequencing database of the tumor niche from 10 newly diagnosed MM patients, we created a unique dataset allowing the in-depth analyses of stromal-immune interactions within the tumor microenvironment. Using this database, we identified the presence of inflammatory stromal fibroblasts in the bone marrow of Myeloma patients.The stromal inflammation was associated with NF-?B signaling, and sources of IL-1ß or TNFa were specific immune subsets previously shown to be altered in MM, suggesting the presence of an immune cell-mediated feed-forward loop of bone marrow inflammation in MM. By tracking inflammatory signatures over time in individual patients undergoing first-line treatment using bulk RNA sequencing, we show that bone marrow inflammation is not reverted by successful anti-tumor therapy (see related accession number), suggesting a role for stromal fibroblasts and bone marrow inflammation in disease persistence or relapse.","By generating a paired single cell RNA-sequencing database of the tumor niche from 10 newly diagnosed MM patients, we created a unique dataset allowing the in-depth analyses of stromal-immune interactions within the tumor microenvironment. Using this database, we identified the presence of inflammatory stromal fibroblasts in the bone marrow of Myeloma patients.The stromal inflammation was associated with NF-?B signaling, and sources of IL-1ß or TNFa were specific immune subsets previously shown to be altered in MM, suggesting the presence of an immune cell-mediated feed-forward loop of bone marrow inflammation in MM. By tracking inflammatory signatures over time in individual patients undergoing first-line treatment using bulk RNA sequencing, we show that bone marrow inflammation is not reverted by successful anti-tumor therapy (see related accession number), suggesting a role for stromal fibroblasts and bone marrow inflammation in disease persistence or relapse.",,,ERA3147950,,Dept. of Hematology Erasmus MC,European Nucleotide Archive,center,Dept. of Hematology Erasmus MC,,64,,,,,,2020-11-19,2020-11-18,2020-11-19,2020-11-18,SAMEA7587660,Dept. of Hematology Erasmus MC,Dept. of Hematology Erasmus MC,2020-11-19T04:05:23Z,2020-11-18T19:54:39Z,public,E-MTAB-91391605724980:Sample 50,human,,,,,,,,,,E-MTAB-91391605724980:Sample 50,,,,,,,,,normal,,ArrayExpress,,adult,CBM16,bone marrow,2020-10-01,2020-06-01,,,,,,,,,,,,,bone marrow cell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,normal,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CD38+ hematopoietic cells,Aortic valve stenosis,CD38+ hematopoietic cells,bone marrow microenvironment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,25,11.627906976744185
ERR4851512,2025-11-17T08:10:05.723781,"                                <Run acc=""ERR4851511"" total_spots=""49813060"" total_bases=""4532988460"" load_done=""true"" is_public=""true"" cluster_name=""public"" static_data_available=""true""/><Run acc=""ERR4851512"" total_spots=""50630199"" total_bases=""4607348109"" load_done=""true"" is_public=""true"" cluster_name=""public"" static_data_available=""true""/>                                ",,,ERR4851511,49813060.0,4532988460.0,1459808947.0,2020-11-20 13:43:46,,ERX4720938,Illumina NovaSeq 6000 sequencing; Paired scRNAseq of the and non-hematopoietic and the immune microenvironment of aspirates from newly diagnosed Multiple Myeloma patients versus non-cancer controls,RNA-Seq,TRANSCRIPTOMIC SINGLE CELL,RANDOM,SINGLE,Sample 46_p,Paired scRNAseq of the and non-hematopoietic and the immune microenvironment of aspirates from newly diagnosed Multiple Myeloma patients versus non-cancer controls,ILLUMINA,Illumina NovaSeq 6000,,ERS5345982,Sample 46,Homo sapiens,9606.0,"Protocols: Viably frozen bone marrow aspirates were thawed in DMEM + 10% FCS according to the 10X Genomics protocol 'Fresh Frozen Human Peripheral Blood Mononuclear Cells for Single Cell RNA sequencing'. Only samples containing >200x10E6 MNCs were included. Fc receptors were blocked in 10% normal human AB serum (Sigma-Aldrich). To enrich for stromal fibroblasts, samples were incubated with biotinylated antibodies against CD45 (clone HI30, BioLegend), CD235a (clone HIR2, BioLegend) and CD38 (from human CD38 MicroBead Kit, Miltenyi Biotec) followed by depletion using magnetic anti-biotin beads (Miltenyi Biotec) and the iMag (BD Biosciences). After depletion, cells were stained for sorting in PBS containing 2% FCS at 4°C with the following antibodies: CD271-PE (ME20.4), CD235a-PECy7 (HI264), CD31-APCCy7 (WM59), CD44-BV711 (IM7), streptavidin-BV421 (all BioLegend), CD34-PECF610 (4H11, eBioscience), CD45-APC (2D1, eBioscience), CD38-FITC (MHCD3801, Life Technologies), CD71-Alexa Fluor 700 (MEM-75, ExBio) and CD105-BV510 (266, BD Biosciences). 7AAD (Beckman Coulter) or DAPI (Life Technologies) were used for dead cell exclusion. Cells were sorted in DMEM + 10% FCS using a FACSAria III (BD Biosciences). Prior to depletion, 10x106 cells were used to sort CD45+CD38- and CD38+ hematopoietic populations using the same antibody panel. Sorted CD45- cells were combined with sorted CD45+CD38- cells and processed as one sample. Single cells were encapsulated for cDNA synthesis and barcoded using the Chromium Single Cell 3' Reagent Kit v3 (10X Genomics) Libraries were constructed according to the manufacturer's recommendations (10X Genomics)",,,,,,,,,,,female,,,,,,,,ERP122056,Paired scRNAseq of the and non-hematopoietic and the immune microenvironment of aspirates from newly diagnosed Multiple Myeloma patients versus non-cancer controls,"By generating a paired single cell RNA-sequencing database of the tumor niche from 10 newly diagnosed MM patients, we created a unique dataset allowing the in-depth analyses of stromal-immune interactions within the tumor microenvironment. Using this database, we identified the presence of inflammatory stromal fibroblasts in the bone marrow of Myeloma patients.The stromal inflammation was associated with NF-?B signaling, and sources of IL-1ß or TNFa were specific immune subsets previously shown to be altered in MM, suggesting the presence of an immune cell-mediated feed-forward loop of bone marrow inflammation in MM. By tracking inflammatory signatures over time in individual patients undergoing first-line treatment using bulk RNA sequencing, we show that bone marrow inflammation is not reverted by successful anti-tumor therapy (see related accession number), suggesting a role for stromal fibroblasts and bone marrow inflammation in disease persistence or relapse.","By generating a paired single cell RNA-sequencing database of the tumor niche from 10 newly diagnosed MM patients, we created a unique dataset allowing the in-depth analyses of stromal-immune interactions within the tumor microenvironment. Using this database, we identified the presence of inflammatory stromal fibroblasts in the bone marrow of Myeloma patients.The stromal inflammation was associated with NF-?B signaling, and sources of IL-1ß or TNFa were specific immune subsets previously shown to be altered in MM, suggesting the presence of an immune cell-mediated feed-forward loop of bone marrow inflammation in MM. By tracking inflammatory signatures over time in individual patients undergoing first-line treatment using bulk RNA sequencing, we show that bone marrow inflammation is not reverted by successful anti-tumor therapy (see related accession number), suggesting a role for stromal fibroblasts and bone marrow inflammation in disease persistence or relapse.",,,ERA3147950,,Dept. of Hematology Erasmus MC,European Nucleotide Archive,center,Dept. of Hematology Erasmus MC,,80,,,,,,2020-11-19,2020-11-18,2020-11-19,2020-11-18,SAMEA7587656,Dept. of Hematology Erasmus MC,Dept. of Hematology Erasmus MC,2020-11-19T04:05:23Z,2020-11-18T19:54:39Z,public,E-MTAB-91391605724980:Sample 46,human,,,,,,,,,,E-MTAB-91391605724980:Sample 46,,,,,,,,,normal,,ArrayExpress,,adult,CBM12,bone marrow,2020-10-01,2020-06-01,,,,,,,,,,,,,bone marrow cell,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,normal,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CD38+ hematopoietic cells,Aortic valve stenosis,CD38+ hematopoietic cells,bone marrow microenvironment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,25,11.627906976744185
